Brave little world - Spheroids as an in vitro model to study tumor-immune-cell interactions

被引:71
|
作者
Gottfried, Eva
Kunz-Schughart, Leoni A.
Andreesen, Reinhard
Kreutz, Marina [1 ]
机构
[1] Univ Regensburg, Dept Hematol & Oncol, D-93042 Regensburg, Germany
[2] Univ Regensburg, Inst Pathol, D-93042 Regensburg, Germany
关键词
spheroid; immune escape; dendritic cell; monocyte; lactic acid; lactate; tumor microenvironment;
D O I
10.4161/cc.5.7.2624
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Multicellular tumor spheroids (MCTS) are a well-established 3-D in vitro model system that reflects the pathophysiological in vivo situation in tumor microregions and of avascular micrometastatic sites. Because monocytes and other immune cells infiltrate into MCTS of different origin, such spheroid cocultures are a valuable, still underestimated tool to systematically study heterologous interactions between tumor and immune cells. The present article gives a brief overview on work that has been published on tumor-immune cell interactions in MCTS and also summarizes mechanisms of immune suppression in the tumor milieu focussing on myeloid cells. Using the coculture model, we recently demonstrated that tumor-derived lactic acid is a potent modulator of human monocyte as lactic acid inhibited the differentiation of monocytes (MO) into dendritic cells (DC) and also impaired antigen presentation. We show herein, that the capacity of various tumor cells in MCTS to secrete lactic acid differs up to tenfold, suggesting that this capacity is dependent on the tumor cell type. It is further demonstrated that lactic acid disturbs the migration of MO into MCTS as infiltration could be increased by blocking lactic acid production. We therefore discuss lactic acid which accumulates in many tumors and tumor microregions as a potent immune suppressor for MO/DC in the tumor milieu and conclude that these data are highly relevant for adoptive immunotherapy protocols with DC.
引用
收藏
页码:691 / 695
页数:5
相关论文
共 50 条
  • [1] Multicellular spheroids as an in vitro tumor model
    Hamilton, G
    CANCER LETTERS, 1998, 131 (01) : 29 - 34
  • [2] Engineering Biomaterials to Model Immune-Tumor Interactions In Vitro
    Skirzynska, Arianna
    Xue, Chang
    Shoichet, Molly S.
    ADVANCED MATERIALS, 2024, 36 (19)
  • [3] A single-cell-based model of tumor growth in vitro:: monolayers and spheroids
    Drasdo, D
    Höhme, S
    PHYSICAL BIOLOGY, 2005, 2 (03) : 133 - 147
  • [4] Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment
    Giustarini, Giulio
    Teng, Germaine
    Pavesi, Andrea
    Adriani, Giulia
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Microencapsulated multicellular tumor spheroids as an in vitro model to study small size tumors
    Markvicheva, E.
    Zaitseva-Zotova, D.
    Akopova, T.
    Zelenetski, A.
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2007, 86 : 63 - 63
  • [6] Microencapsulated multicellular tumor spheroids as a novel in vitro model for drug screening
    Tsoy A.M.
    Zaytseva-Zotova D.S.
    Edelweiss E.F.
    Bartkowiak A.
    Goergen J.-L.
    Vodovozova E.L.
    Markvicheva E.A.
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2010, 4 (3) : 243 - 250
  • [7] Multicellular tumor spheroids: A convenient in vitro model for translational cancer research
    Patel, Tushar
    Jain, Neeraj
    LIFE SCIENCES, 2024, 358
  • [8] A mathematical model of tumor-immune interactions
    Robertson-Tessi, Mark
    El-Kareh, Ardith
    Goriely, Alain
    JOURNAL OF THEORETICAL BIOLOGY, 2012, 294 : 56 - 73
  • [9] A zebrafish xenotransplant model of anaplastic thyroid cancer to study tumor microenvironment and innate immune cell interactions in vivo
    Michael, Cassia
    Mendonca-Gomes, Juliana Moreira
    Depaolo, Clinton Walton
    Di Cristofano, Antonio
    de Oliveira, Sofia
    ENDOCRINE-RELATED CANCER, 2024, 31 (07)
  • [10] Wilms Tumor Spheroids are a Powerful in Vitro Model for High-Risk Blastemal Wilms Tumor
    Wegert, J.
    Zauter, L.
    Appenzeller, S.
    Vokuhl, C.
    Otto, C.
    Furtwaengler, R.
    Graf, N.
    Gessler, M.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S378 - S379